Aug 2026· Genetics and Molecular Research· 0 citations· 35 references
TL;DR
Emerging biomarkers, advanced imaging approaches, and risk prediction models are discussed as tools that may enhance stratification and support personalized management, while ongoing challenges include disease heterogeneity, methodological limitations, and delayed recognition of progressive injury.
Abstract
Chronic kidney disease (CKD) is a heterogeneous, progressive condition where the measurement of functional aspects and clinical phenotypes might not be sufficient in evaluating the underlying structural damage. This review synthesizes evidence on clinicopathological correlation in CKD and evaluates how integrating histopathology with clinical assessment, laboratory markers, and imaging improves diagnostic precision and prognostic assessment. Key clinicopathological relationships are highlighted, including how proteinuria and active urinary sediment often signal glomerular injury, whereas declining renal function frequently aligns with the burden of tubulointerstitial fibrosis and vascular disease. The review also examines how pathological severity generally increases with advancing CKD stage, limiting reversibility and narrowing therapeutic windows. Importantly, discordance between presumed clinical diagnoses and biopsy findings is common in systemic and comorbidity-driven CKD, underscoring the value of tissue-based evaluation in selected cases. A multidisciplinary framework involving nephrology, pathology, radiology, and laboratory medicine is emphasized as essential for integrated interpretation and individualized care. Emerging biomarkers, advanced imaging approaches, and risk prediction models are discussed as tools that may enhance stratification and support personalized management, while ongoing challenges include disease heterogeneity, methodological limitations, and delayed recognition of progressive injury. Clinicopathological integration provides a robust pathway toward more accurate classification, targeted intervention, and improved outcomes in CKD.
This review offers an extensive review of CKD pathophysiology and consequences, paying special attention to the role played by inflammation, oxidative stress, and fibrosis, and presents CKD biomarkers in accordance with their functions and discusses their advantages and disadvantages.
M. Chhillar, Poornima Bhatt· Clinica chimica acta; intern...· 0 citations
Overall, early diagnosis in fibrosing ILD should be regarded as a therapeutic intervention in itself, capable of modifying the natural history of the disease, improving quality of life, and reducing both the economic and emotional burden for patients and healthcare systems.
Vicente R Castro, Florencia M Villarroel, Silvia Quadrelli· Medicina· 0 citations
Early identification is essential for risk stratification, lung transplant evaluation, and determining eligibility for targeted pharmacological interventions, as this group of patients remains one of the most therapeutically challenging forms of pulmonary vascular disease.
E. Vasarmidi, Diana Calaras, I. Kourouni et al.· International Journal of Mol...· 0 citations
Kidney imaging advances are transforming the field of nephrology by allowing non-invasive examination of renal structure, function, and pathology, and imaging biomarkers show significant predictive value for progression to kidney failure in CKD, including diabetic kidney disease, independent of traditional measurements...
Mustafa Guldan, Ibrahim Gulmaliyev, Rama Al-Shiab et al.· Clinical Kidney Journal· 0 citations
Chronic kidney disease of unknown etiology (CKDu) affects residents of distinct clusters of rural communities in Central America, Sri Lanka, and India. Affected persons may lack conventional metabolic or vascular risk factors for CKD and present with declining kidney function in the absence of significant proteinuria....
M. C. Nieves, N. Nanayakkara, Ramón García-Trabanino et al.· Nephrology, Dialysis and Tra...· 0 citations
BACKGROUND
Primary glomerular diseases (PGDs) are not uncommon in elderly patients, where age-related histological changes, frailty, and multimorbidity overlap with disease-specific drivers of damage. Evidence on the impact of older age at onset on PGD presentation and outcomes remains heterogeneous. This retrospective...
Martina Tedesco, Federica Mescia, Becky Ma Mingyiao et al.· American Society of Nephrolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.